Product Releases

New Dissolution Apparatus From Varian, Inc. Enables Testing Of Combinatorial Drug-Device Products

Varian’s new dissolution system is designed to simplify  the testing of drug formulations with extremely low quantities of active ingredients.  The 400-DS meets the compendial  requirements of  a USP Apparatus 7, supports the testing of combinatorial products in which small amounts of drug are combined as part of a medical device such as a stent or implant.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters